Dalton Medicial Chemistry was built on 30 years of strength and excellence at Dalton Pharma Services. Dalton Medicinal Chemistry is a highly focused team of committed, knowledgeable medicinal chemists with expertise in small molecule drug discovery and development.
Dalton Medicinal Chemistry augments your in-house expertise and capabilities, serving as an extension of your own R&D group and as a responsive and reliable partner. We work closely with our partners to design and synthesize compounds for their targets and assays, leading ultimately to the identification of development candidates.
Our track record of identifying novel chemical entities for your Discovery/Development pipelines has been demonstrated todate through three publicly announced partnerships with Biotech (BioRelix & Bikam) and Pharma (Boehringer Ingelheim).
Dalton Medicinal Chemistry Focus
Dalton Medicinal Chemistry Expertise
Dalton Medicinal Chemistry offers significant experience in Fragment-to-Lead, Hit-to-Lead, and Lead Optimization capabilities in advancing compounds to development against a wide variety of target types and therapeutic areas.
Selected Areas of Previous Experience
Dalton Medicinal Chemistry
Founder and President
Dalton Pharma Services